Cal Water (CWT) Q1 2026 Earnings Call Transcript

California Water Service Group reported Q1 revenue of $214.6 million, up 5.2% year over year, but EPS fell to $0.07 from $0.22 as higher depreciation, interest expense, lower consumption, and a higher tax rate pressured earnings. Management highlighted constructive progress on the 2024 California GRC, with projected revenue increases of about $91 million in 2026, $43 million in 2027, and $49 million in 2028, plus ongoing M&A activity in Nevada, Oregon, and Texas. The board declared its 325th consecutive quarterly dividend at $0.335 per share and raised the 2026 annual dividend 8.1% to $1.34.

Analysis

The core signal here is not the quarter itself; it’s that the company is converting regulatory lag into a deferred earnings step-up. Once the revised California decision is finalized, the near-term optics should improve mechanically because the company can backfill revenue from January 1, while the billing implementation burden mostly hits ops rather than cash flow. That creates a cleaner catalyst path over the next 1-2 quarters, with the real upside showing up in 2H26 as the new tariff stack and retroactive recovery flow through.

The bigger second-order effect is balance-sheet optionality versus dilution. Management is effectively telling you that equity issuance will be timed around acquisition closings, not day-to-day capex, which lowers the probability of a near-term equity overhang; using forwards instead of spot ATM sales is a subtle positive because it reduces headline dilution risk and can mute multiple compression. The flip side is that this is still a levered regulated utility with a rising capex base, so if regulatory execution slips or acquisition timing drifts beyond year-end, funding needs can move back into the stock.

The market may be underappreciating how much of the “growth” is now being outsourced to regulation, litigation recovery, and M&A rather than organic demand. That makes the story more durable than a weather-driven quarter, but also more brittle if any one of the three levers stalls. The cleanest contrarian read is that the stock is more of a financing/regulatory arb than an operating consumption story; if the final order lands as expected, sentiment should improve, but the upside is probably capped unless investors start paying for the multi-year rate-base growth trajectory instead of just the dividend.

Key Decisions for Investors

• Long CWT on confirmation of the final California decision; trade into the 1-2 quarter re-rating window as retroactive recovery and rate implementation become visible. Risk/reward is favorable if the market is still pricing in regulatory slippage, but trim on any post-decision gap-up because the next catalyst is execution, not incremental surprise.
• Buy CWT vs. short a broader utility basket proxy (e.g., XLU) over 3-6 months. The stock has a more explicit near-term catalyst stack than peers, while the rest of the sector lacks the same mix of retroactive rate recovery, PFAS offsets, and acquisition-related growth.
• Avoid chasing the common stock ahead of acquisition closings; instead, wait for any equity-market weakness tied to financing headlines. If management uses forwards/ATM tactically, entry on dilution-driven dips offers better risk/reward than buying into enthusiasm around M&A.